Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John H Yim

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
The American Journal of Surgical Pathology|September 25, 2008
Parathyroid lipoadenomas and lipohyperplasias: clinicopathologic correlationsRaja R Seethala, Jennifer B Ogilvie, Sally E Carty, et al.
Cancer Biology & Therapy|May 27, 2015
IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibitionMichaele J Armstrong, Michael T Stang, Ye Liu, et al.
Surgery|December 12, 2003
Loss of heterozygosity of the VHL gene identifies malignancy and predicts death in follicular thyroid tumorsJennifer L Hunt, John H Yim, Michael Tometsko, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 21, 2003
The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human breast carcinoma cell linesJohn H Yim, Simon H Ro, Jennifer K Lowney, et al.
Surgery|December 8, 2007
The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in sizeKelly L McCoy, Noel Jabbour, Jennifer B Ogilvie, et al.
World Journal of Surgery|March 8, 2008
Can a lightbulb sestamibi SPECT accurately predict single-gland disease in sporadic primary hyperparathyroidism?Linwah Yip, Daniel A Pryma, John H Yim, et al.
Cancers|September 15, 2020
Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian CancerWei Wen, Ernest S Han, Thanh H Dellinger, et al.
Oncotarget|June 1, 2018
Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancerErnest S Han, Wei Wen, Thanh H Dellinger, et al.
International Journal of Molecular Sciences|November 27, 2025
Therapeutic Potential of Baicalein in Endometrial Cancer: Suppression of mTOR Signaling and Synergy with MetforminAlison L Dumitriu, Wei Wen, Jin Yan, et al.
Archives of Surgery (Chicago, Ill. : 1960)|January 21, 2009
Cystic parathyroid lesions: functional and nonfunctional parathyroid cystsKelly L McCoy, John H Yim, Brian S Zuckerbraun, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
The American Journal of Surgical Pathology|September 25, 2008
Parathyroid lipoadenomas and lipohyperplasias: clinicopathologic correlationsRaja R Seethala, Jennifer B Ogilvie, Sally E Carty, et al.
Cancer Biology & Therapy|May 27, 2015
IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibitionMichaele J Armstrong, Michael T Stang, Ye Liu, et al.
Surgery|December 12, 2003
Loss of heterozygosity of the VHL gene identifies malignancy and predicts death in follicular thyroid tumorsJennifer L Hunt, John H Yim, Michael Tometsko, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 21, 2003
The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human breast carcinoma cell linesJohn H Yim, Simon H Ro, Jennifer K Lowney, et al.
Surgery|December 8, 2007
The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in sizeKelly L McCoy, Noel Jabbour, Jennifer B Ogilvie, et al.
World Journal of Surgery|March 8, 2008
Can a lightbulb sestamibi SPECT accurately predict single-gland disease in sporadic primary hyperparathyroidism?Linwah Yip, Daniel A Pryma, John H Yim, et al.
Cancers|September 15, 2020
Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian CancerWei Wen, Ernest S Han, Thanh H Dellinger, et al.
Oncotarget|June 1, 2018
Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancerErnest S Han, Wei Wen, Thanh H Dellinger, et al.
International Journal of Molecular Sciences|November 27, 2025
Therapeutic Potential of Baicalein in Endometrial Cancer: Suppression of mTOR Signaling and Synergy with MetforminAlison L Dumitriu, Wei Wen, Jin Yan, et al.
Archives of Surgery (Chicago, Ill. : 1960)|January 21, 2009
Cystic parathyroid lesions: functional and nonfunctional parathyroid cystsKelly L McCoy, John H Yim, Brian S Zuckerbraun, et al.
Pageof 6